SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021237
Filing Date
2023-05-11
Accepted
2023-05-11 16:11:19
Documents
64
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hrtx-20230331.htm   iXBRL 10-Q 1616519
2 EX-31.1 hrtx-ex31_1.htm EX-31.1 20477
3 EX-31.2 hrtx-ex31_2.htm EX-31.2 20090
4 EX-32.1 hrtx-ex32_1.htm EX-32.1 23485
  Complete submission text file 0000950170-23-021237.txt   7075822

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hrtx-20230331_pre.xml EX-101.PRE 270281
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hrtx-20230331_lab.xml EX-101.LAB 374888
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hrtx-20230331_def.xml EX-101.DEF 149092
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hrtx-20230331.xsd EX-101.SCH 40451
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hrtx-20230331_cal.xml EX-101.CAL 42884
58 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-20230331_htm.xml XML 1477150
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 23911116
SIC: 2834 Pharmaceutical Preparations